Antioxidant compounds from Annona crassiflora fruit peel reduce lipid levels and oxidative damage and maintain the glutathione defense in hepatic tissue of Triton WR-1339-induced hyperlipidemic mice

Biomed Pharmacother. 2021 Oct:142:112049. doi: 10.1016/j.biopha.2021.112049. Epub 2021 Aug 23.

Abstract

Dyslipidemia is a risk factor for the pathogenesis of several diseases, such as obesity, hypertension, atherosclerosis and cardiovascular diseases. In addition to interfering with serum concentrations of cholesterol and triglycerides, hyperlipidemia is involved in oxidative stress increase and reduction of the endogenous antioxidant defenses. The fruit peel of Annona crassiflora crude extract (CEAc) and its polyphenols-rich fraction (PFAc) were investigated against hypertriglyceridemia, hypercholesterolemia and hepatic oxidative stress in Triton WR-1339-induced hyperlipidemic mice. Lipid parameters in serum, feces and liver, as well as hepatic oxidative status, and enzymatic and non-enzymatic antioxidant defense systems were analyzed. Pre-treatment with CEAc for 12 days decreased hepatic triglycerides and total cholesterol, and similar to PFAc, increased the high-density lipoprotein level. There were reductions in lipid peroxidation and protein carbonylation, as well as restoration of the glutathione defense system and total thiol content in the liver of the hyperlipidemic mice treated with PFAc. The fruit peel of A. crassiflora, a promising natural source of bioactive molecules, showed a potential lipid-lowering action and hepatoprotective activities triggered by reduction of oxidative damage and maintenance of the enzymatic and non-enzymatic antioxidant systems impaired by the hyperlipidemic state.

Keywords: Antioxidant activity; Dyslipidemia; Glutathione system; Liver; Phenolic compounds.

MeSH terms

  • Animals
  • Annona / chemistry*
  • Antioxidants / isolation & purification
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Cholesterol / metabolism
  • Fruit / chemistry
  • Glutathione / metabolism*
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / isolation & purification
  • Hypolipidemic Agents / pharmacology*
  • Hypolipidemic Agents / therapeutic use
  • Lipid Metabolism / drug effects
  • Lipid Peroxidation / drug effects
  • Liver / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress / drug effects
  • Oxidoreductases / metabolism
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Polyethylene Glycols / toxicity
  • Polyphenols / isolation & purification
  • Polyphenols / pharmacology*
  • Polyphenols / therapeutic use
  • Protein Carbonylation / drug effects
  • Triglycerides / metabolism

Substances

  • Antioxidants
  • Hypolipidemic Agents
  • Plant Extracts
  • Polyphenols
  • Triglycerides
  • Polyethylene Glycols
  • Cholesterol
  • Oxidoreductases
  • Glutathione
  • tyloxapol